Abstract
There have been an increasing number of lawsuits claiming compensation for injuries related to vaccines. Increased litigation can be expected to result in reluctance on the part of some practitioners to use certain vaccines, consideration in changes in recommendations for immunization, and increased cost of vaccines. The costs of oral polio vaccine (OPV) and diphtheria-tetanus-pertussis (DTP) vaccine have been increased markedly presumably because of litigation. It is estimated that the nearly tenfold increase in DTP vaccine charged by one manufacturer could add approximately $50 million per year to the cost of protecting children against these diseases. Manufacturers have been leaving the vaccine business and now only a few remain.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.